Superficial radiation therapy provider Sensus Healthcare is directing attention to the results of a study that assessed the performance of its SRT-100 system for treating nonmelanoma skin cancer patients.
In the five-year retrospective study performed across four sites in the U.S., superficial radiation therapy yielded a 98.9% cure rate within a group of 516 patients with 776 nonmelanoma skin cancer lesions, according to Sensus. The researchers, led by Dr. William Roth of the University of Miami School of Medicine, reported an estimated 1.1% cumulative recurrence rate among the patients for all tumors, as well as five-year cumulative recurrence rates of 1.2% for patients with basal cell carcinoma and 0.9% for those with squamous cell carcinoma.
